Steroid sulfates inhibitors as novel additions to the antipsoriatic armamentarium

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Namazi, Mohammad R ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Cytokines; Dehydroepiandrosterone; Psoriasis; Steroid sulfatase; Steroid sulfataso inhibitors; Treatment

Indexed keywords

ANTIPSORIASIS AGENT; CALCIPOTRIOL; CHOLESTEROL SULFATE; PRASTERONE; PRASTERONE SULFATE; STEROID SULFATASE INHIBITOR; STERYL SULFATASE; UNCLASSIFIED DRUG; CALCITRIOL; CYTOKINE; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR;

DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; LYMPHOID TISSUE; PSORIASIS; REVIEW; T LYMPHOCYTE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; MOUSE; MOUSE STRAIN; PHYSIOLOGY;

ANIMALS; CALCITRIOL; CYTOKINES; DEHYDROEPIANDROSTERONE; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; ENZYME INHIBITORS; MICE; MICE, INBRED STRAINS; MODELS, BIOLOGICAL; PSORIASIS; STERYL-SULFATASE;

EID: 15944376210     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Krueger JG: The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002; 46: 1-23
2. Zalewska A, Wyczolkowska J, Dziankowska-Bartkowiak B, Sysa-Jedrzejowska A: Interleukin 4 plasma levels in psoriasis vulgaris patients. Med Sci Monit, 2004; 10(4): CR156-CR162
3. Bos JD, Hulsebosch HJ, Krieg SR et al: Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res, 1983; 275: 181-89
4. Austin LM, Ozawa M, Kikuchi T et al: The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TCl (cytotoxic T lymphocytes) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood cells in psoriasis patients J Invest Dermatol, 1999; 113: 752-59
5. Cather J, Menter A: Novel therapies for psoriasis. Am J Clin Dermatol, 2002; 3(2): 159-73
6. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature, 1998; 392: 245-52
7. Dieu-Nosjean MC, Massacrier C, Homey B et al: Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med, 2000; 192: 705-17
8. Meikle AW, Daynes RA, Araneo BA: Adrenal androgen secretion and biologic effects. Endocrinol Metabol Clin North Am, 1991; 20(2): 381-400
9. Daynes RA, Araneo BA, Dowell TA et al: Regulation of murine lymphokine production in vivo III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med, 1990; 171: 979-96
10. Dames RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol, 1990; 20: 793-802
11. Meeusen ENT, Premier RR, Brandon MR: Tissue-specific migration of lymphocytes: a key role for TH1 and TH2 cells? Immunol Today, 1996; 17(9): 421-24
12. th ed, Oxford: Blackwell science, 1998, pp 1490